Drimva

GSK

Medical Director Clinical Development- Aging

$190K–$316K

USA - Massachusetts - Waltham +3 · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 14, 2026

Location
USA - Massachusetts - Waltham
UK - Hertfordshire - Stevenage
UK - London
USA - Pennsylvania - Upper Providence
Experience
No specific number of years stated.
Education
Medical Degree; formal postgraduate clinical training, clinical residency, or specialty training.

About the job

Leads clinical and translational development strategy for aging-related programs, designing studies and overseeing evidence generation, participant safety, and cross-functional decisions from early development onward.

What you'll do

  • Lead clinical development strategy and the Clinical Matrix Team for programs; design development plans, protocols, and studies.
  • Oversee medical monitoring, participant safety, medical governance, and clinical data interpretation; contribute to regulatory documents and interactions.
  • Coordinate cross-functional teams to generate translational and clinical evidence, meet study timelines, and support program decisions.

What they ask for

  • Medical Degree and completion of formal postgraduate clinical training, clinical residency, or specialty training.
  • Demonstrated experience in clinical trial conduct, including medical monitoring, safety review, and clinical data interpretation.
  • Strong working knowledge of clinical development processes, including GCP, ICH guidelines, and global regulatory frameworks.
  • Experience in cross-functional matrix teams in a pharmaceutical, biotechnology, or academic clinical trial environment.

Nice to have

  • Experience in pharmaceutical or biotechnology clinical development across early-phase studies; relevant clinical specialty or therapeutic-area experience.
  • Knowledge of aging research priorities, public health needs, and the competitor landscape.

Pay

USD 189,750 to USD 316,250 annual base salary

Tools

GCP, ICH guidelines

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)